Entecavir resistance is rare in nucleoside naïve patients with hepatitis BRichard J. Colonno, Daniel J. Tenney, Ann W. Walsh et al.|Hepatology|2006Cited by 348
Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions PresentDaniel J. Tenney, Richard J. Colonno, Ronald E. Rose et al.|Antimicrobial Agents and Chemotherapy|2006Cited by 239
Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in MiceDavid Surguladze, James R. Tonra, Dhanvanthri S. Deevi et al.|Unknown|2023Cited by 0